Is it good for us ??? welcome to discuss...
http://finance.yahoo.com/q/ao?s=MIR.V
more news today:
HALIFAX, March 22 /PRNewswire-FirstCall/ - MedMira Inc. ("MedMira") (TSX Venture: MIR) today announced that the company has completed an initial shipment of 100,000 MiraWell(TM) Rapid HIV Tests to the People's Republic of China. The shipment is the first portion of an annual commitment of 1.3 million kits from a new distributor, which replaces the agreement previously announced with Long Hao Healthcare Technology Company Ltd., of Guangzhou, China. This marks the first Canadian commercially available Rapid HIV test to ever be shipped to China.
The new distributor is highly experienced in the distribution of medical products and devices. This agreement covers the 8 provinces they serve in southwestern and northeastern China.
"The China market is a difficult one with many complex distribution channels and it has taken several months of active work to achieve the type of business arrangements we sought," said Stephen Sham, MedMira chairman and CEO, "but with this new contract, volumes are substantial, and we have a strong start in opening the entire China market for MedMira products."
MedMira (http://www.medmira.com) is a commercial biotechnology company that develops, manufactures and markets qualitative, in vitro diagnostic tests for the detection of antibodies to certain diseases, such as HIV, in human serum, plasma or whole blood. The United States FDA and the SFDA in the People's Republic of China have approved MedMira's Reveal(TM) and MiraWell(TM) Rapid HIV Tests, respectively.
All of MedMira's diagnostic tests are based on the same flow-through technology platform, thus facilitating the development of future products. MedMira's technology provides a quick (under 3 minutes), accurate, portable, safe and cost-effective alternative to conventional laboratory testing.
.
http://finance.yahoo.com/q/ao?s=MIR.V
more news today:
HALIFAX, March 22 /PRNewswire-FirstCall/ - MedMira Inc. ("MedMira") (TSX Venture: MIR) today announced that the company has completed an initial shipment of 100,000 MiraWell(TM) Rapid HIV Tests to the People's Republic of China. The shipment is the first portion of an annual commitment of 1.3 million kits from a new distributor, which replaces the agreement previously announced with Long Hao Healthcare Technology Company Ltd., of Guangzhou, China. This marks the first Canadian commercially available Rapid HIV test to ever be shipped to China.
The new distributor is highly experienced in the distribution of medical products and devices. This agreement covers the 8 provinces they serve in southwestern and northeastern China.
"The China market is a difficult one with many complex distribution channels and it has taken several months of active work to achieve the type of business arrangements we sought," said Stephen Sham, MedMira chairman and CEO, "but with this new contract, volumes are substantial, and we have a strong start in opening the entire China market for MedMira products."
MedMira (http://www.medmira.com) is a commercial biotechnology company that develops, manufactures and markets qualitative, in vitro diagnostic tests for the detection of antibodies to certain diseases, such as HIV, in human serum, plasma or whole blood. The United States FDA and the SFDA in the People's Republic of China have approved MedMira's Reveal(TM) and MiraWell(TM) Rapid HIV Tests, respectively.
All of MedMira's diagnostic tests are based on the same flow-through technology platform, thus facilitating the development of future products. MedMira's technology provides a quick (under 3 minutes), accurate, portable, safe and cost-effective alternative to conventional laboratory testing.
.
